Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01HL141123, R01-HL148109, T32 HL007284
Fondation Leducq
Grant: Transatlantic Networks of Excellence: B cells in cardiovascular disease
NCI NIH HHS
Grant: P30 CA044579
NHLBI NIH HHS
Grant: R01 HL141123
NHLBI NIH HHS
Grant: R01 HL148109
NHLBI NIH HHS
Grant: T32 HL007284
NHLBI NIH HHS
Grant: P01 HL136275
National Institutes of Health
Grant: 1R01HL148109-01
Id3 and VSMC in Murine and Human Atherosclerosis
National Institutes of Health
Grant: 3P30CA044579-19S1
Cancer Center Support Grant
National Institutes of Health
Grant: 5T32HL007284-12
BASIC CARDIOVASCULAR RESEARCH
National Institutes of Health
Grant: 5R01HL141123-04
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
Fields of Study
MeSH Terms
Keywords